Here's how LINKINGHUB.ELSEVIER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINKINGHUB . ELSEVIER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Linkinghub.elsevier.com Make Money
  6. Keywords
  7. Topics
  8. External Links
  9. Libraries
  10. CDN Services

We are analyzing https://linkinghub.elsevier.com/retrieve/pii/s0939641123001698.

Title:
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment - ScienceDirect
Description:
The objective of this study is to develop hydroxyapatite (HAp) particles for targeted delivery of honokiol to tumor sites after glioma surgical manage…
Website Age:
32 years and 0 months (reg. 1993-07-02).

Matching Content Categories {πŸ“š}

  • Science
  • Health & Fitness
  • Insurance

Content Management System {πŸ“}

What CMS is linkinghub.elsevier.com built with?

Custom-built

No common CMS systems were detected on Linkinghub.elsevier.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of linkinghub.elsevier.com audience?

🌟 Strong Traffic: 100k - 200k visitors per month


Based on our best estimate, this website will receive around 100,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Linkinghub.elsevier.com Make Money? {πŸ’Έ}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Linkinghub.elsevier.com might be making money, but it's not detectable how they're doing it.

Keywords {πŸ”}

treatment, honokiol, drug, glioma, hap, cancer, delivery, tumor, cells, release, particles, cell, brain, abstract, haphonokiol, system, show, glioblastoma, agents, chemotherapy, surgery, site, gliadel, wafer, carrier, acid, effects, therapy, content, access, european, journal, pharmaceutics, biopharmaceutics, volume, research, hydroxyapatite, study, surgical, synthesized, size, remains, effect, altsc, download, gbm, survival, drugs, antiglioma, application,

Topics {βœ’οΈ}

aptamer-functionalized peg-plga nanoparticles section snippets materials download high-res image chi-shun chiang laboratory inducing mitochondria-dependent apoptosis triple-negative breast cancer local long-term delivery tumor-treating fields world long-acting antidepression treatment anti-glioma chemotherapeutic agents open access content averages approximately 5Β mg/kg discover nano view graphical abstract download hydroxyapatite-based materials drug-carrier system protein powder suspensions hap-honokiol treatment shows high-grade gliomas long-term survival central nervous system drug loading capacity line chemotherapeutic agent form hap-honokiol particles possesses anti-oxidation create porous structures drug delivery carriers anti-depression effects locally release drugs kuo-chi chang compromising drug efficacy exhibits neuroprotective properties experimental malignant gliomas cancer cell uptake low drug penetration mesoporous hydroxyapatite high-dosage drugs yu-chen hsu neutral environments due apoptosis pathway induced surgical management remains bulky size limits achieving efficacious concentrations micro-particle form traditional simple diffusion organometallic tamoxifen derivative stand south asian inflammation-mediated pharmacokinetics cancer cells remaining kill cancer cells

Libraries {πŸ“š}

  • Particles.js

CDN Services {πŸ“¦}

  • Cloudflare
  • Com","assetRoute":"https://sdfestaticassets-us-east-1
  • Com/content/image/","xocsMediaPlayerBaseUrl":"https://sdfestaticassets-us-east-1
  • Com/content/image/1-s2
  • Com/content/image/S09396411
  • Cookielaw
  • Pendo

5.89s.